Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
BI-1347 is an inhibitor of Cdk8 and Cdk19 (IC50s = 1.4 and 1.7 nM, respectively).1 It is selective for Cdk8 and Cdk19 over Cdk1, -2, -4, -6, -7, and -9 and a panel of 318 additional kinases at 1 µM. In vivo, BI-1347 (10 mg/kg) reduces tumor volume in an MV4-11 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Selective and potent CDK8/19 inhibitors enhance NK-